Cited by 16Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchIntracerebral and Subarachnoid Hemorrhage Research

Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene

Niwa, Atsushi, Matsuo, Ko, Shindo, Akihiro, Yata, Kenichiro, Shiraishi, Taizo, Tomimoto, Hidekazu·2013·Neuropathology

Abstract

Over 100 mutations have been described in the presenilin-1 gene (PSEN1), resulting in familial Alzheimer disease (AD). However, of the limited number of autopsy cases, only one has been reported from an AD family with an L420R PSEN1 mutation. We describe here clinical and neuropathological features of a patient with dementia-parkinsonism from a family with a PSEN1 mutation (L420R). A 43-year-old Japanese woman was autopsied 12 years after the onset of her progressive dementia and 4 years after the onset of parkinsonism. Throughout the neocortex and hippocampus, cotton wool plaques were identified, densely packed, in almost all the cortical layers along with neuronal loss, gliosis, NFT and neuropil threads. In addition, CAA affecting meningeal, subpial and cortical arterioles was found, as well as amyloid β-protein (Aβ)-deposition in the capillaries (capillary CAA) in the neocortex and subcortical nuclei. There was loss of pigmented neurons in the substantia nigra. The putamen was densely packed with diffuse plaques and rarely showed capillary CAA, whereas the globus pallidus showed extensive capillary CAA but no plaques. This differential distribution is similar to that reported for a previous patient with a mutation in PSEN1. It is concluded that neuropathological changes in the substantia nigra and lenticular nuclei were responsible for the patient's parkinsonism. Capillary transport of Aβ unique to the respective tissue of the patient may result in the differential distrib…

Integrity signals

Registry

Crossref · 10.1111/j.1440-1789.2012.01340.x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • To date, 228 PSEN1 mutations have been identified causing ADAD.

    “To date, 228 PSEN1 mutations have been identified causing ADAD (49, 303, 304, 440, 566, 580).”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [440]

  • Human PSEN1 mutation carriers have notable BBB breakdown and cerebrovascular dysfunction including cerebellar amyloid angiopathy and CAA, disrupted meningeal, subpial, and cortical arterioles, degeneration of pericytes and SMCs, cerebral perivascular amyloid deposits, and diminished FDG transport across the BBB in an early asymptomatic stage.

    “Human PSEN1 mutation carriers have notable BBB breakdown and cerebrovascular dysfunction including cerebellar amyloid angiopathy and CAA (143, 183, 274, 280, 354, 389, 440, 500, 544, 573, 639, 668); disrupted meningeal, subpial, and cortical arterioles (274, 389, 440); degeneration of pericytes and SMCs (573); cerebral perivascular amyloid deposits (25, 274, 289, 354, 573, 668); and diminished FDG”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [440]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Niwa, A., Matsuo, K., Shindo, A., Yata, K., Shiraishi, T., & Tomimoto, H.
Affiliations
Mie University (JP)
Corresponding author
Niwa, Atsushi
Venue
Neuropathology
Publisher
Wiley
Published
2012-08-12
Volume
33
Issue
2
Pages
199-203
ISSN
  • 0919-6544 (ISSN-L)
  • 1440-1789
OpenAlex
W2096211653
Cited by
16
References
20
Citations by year
2026: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2015: 3 · 2014: 1 · 2012: 1
FWCI
1.07
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords
familial Alzheimer's disease, PSEN1 mutations, cerebral amyloid angiopathy, amyloid-beta deposition, neurofibrillary tangles, putamen, globus pallidus
MeSH terms
Alzheimer Disease, Brain, Female, Humans, Middle Aged, Mutation, Fatal Outcome, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review